Vaccine adjuvant discovery program

Awarded Award Notice Posted

Solicitation number
BAA-DAIT-75N93022R00022
Agency
National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
Awarded
to Institut De Formulation DES Vaccins (Ch) SA
Set-aside
No set-aside

Opportunity facts

Contract number
75N93024C00021 Federal contract award
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Place of performance
Switzerland
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

This Award Notice is for a cost-reimbursement contract awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency under the Department of Health and Human Services, to INSTITUT DE FORMULATION DES VACCINS (CH) SA for the VACCINE ADJUVANT DISCOVERY PROGRAM. The contract, valued at $9,189,961.00, was awarded on September 18, 2024 and involves the discovery and development of vaccine adjuvants, which are substances used to enhance the immune response to a vaccine.

Notice text

This is not fixed-priced. This is a cost-reimbursement contract.

Awarded contract 75N93024C00021 to INSTITUT DE FORMULATION DES VACCINS (CH) SA for 9189961.00 on 2024-09-18.

Notice history

Notices posted for this opportunity, newest first
Notice Type Posted
Vaccine adjuvant discovery program Latest Award Notice
Vaccine adjuvant discovery program Award Notice
Vaccine adjuvant discovery program Award Notice
Vaccine adjuvant discovery program This notice Award Notice
Vaccine adjuvant discovery program Latest solicitation Solicitation
Vaccine adjuvant discovery program Original Pre-Solicitation

And 1 more award notice.

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity